IL-34 is associated with the presence and severity of renal dysfunction and coronary artery disease in patients with heart failure

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Fan, Qin ^a   Yan, Xiaoxiang ^a   Zhang, Hang ^a   Lu, Lin ^a   Zhang, Qi ^a   Wang, Fang ^a   Xi, Rui ^a   Hu, Jian ^a   Chen, Qiujing ^a   Niu, Wenquan ^a   Shen, Weifeng ^a   Zhang, Ruiyan ^a   Tao, Rong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN DERIVATIVE; INTERLEUKIN-34, HUMAN;

AGED; BLOOD; COMPLICATION; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; FEMALE; HEART FAILURE; HUMAN; KIDNEY FAILURE; MALE; MIDDLE AGED; PATHOLOGY;

AGED; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HEART FAILURE; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY;

EID: 85006489817     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep39324     Document Type: Article

References (30)

1. Braunwald, E. The war against heart failure: the Lancet lecture. Lancet 385, 812-824 (2015).
2. Go, A. S., et al. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation 113, 2713-2723 (2006).
3. Mann, D. L. Innate immunity and the failing heart: the cytokine hypothesis revisited. Circ Res 116, 1254-1268 (2015).
4. Bielecka-Dabrowa, A., et al. Biomarkers and echocardiographic predictors of myocardial dysfunction in patients with hypertension. Sci Rep 5, 8916 (2015).
5. Lin, H., et al. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 320, 807-811 (2008).
6. Nakamichi, Y., Udagawa, N., Takahashi, N. IL-34 and CSF-1: similarities and differences. J Bone Miner Metab 31, 486-495 (2013).
7. Eda, H., et al. Macrophage-colony stimulating factor and interleukin-34 induce chemokines in human whole blood. Cytokine 52, 215-220 (2010).
8. Chemel, M., et al. Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients. Ann Rheum Dis 71, 150-154 (2012).
9. Zwicker, S., et al. Interleukin 34: a new modulator of human and experimental inflammatory bowel disease. Clin Sci (Lond) 129, 281-290 (2015).
10. Ciccia, F., et al. IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14(bright)CD16+ monocytes. Rheumatology (Oxford) 52, 1009-1017 (2013).
11. Baek, J. H., et al. IL-34 mediates acute kidney injury and worsens subsequent chronic kidney disease. J Clin Invest 125, 3198-3214 (2015).
12. Bezie, S., et al. IL-34 is a Treg-specific cytokine and mediates transplant tolerance. J Clin Invest 125, 3952-3964 (2015).
13. Metra, M., Cotter, G., Gheorghiade, M., Dei Cas, L., Voors, A. A. The role of the kidney in heart failure. Eur Heart J 33, 2135-2142 (2012).
14. Charoen, P., et al. Mendelian Randomisation study of the influence of eGFR on coronary heart disease. Sci Rep 6, 28514 (2016).
15. Hillege, H. L., et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102, 203-210 (2000).
16. Lassus, J., Harjola, V. P. Cystatin C: a step forward in assessing kidney function and cardiovascular risk. Heart Fail Rev 17, 251-261 (2012).
17. Georgiopoulou, V. V., et al. Renal biomarkers and outcomes in outpatients with heart failure: The Atlanta cardiomyopathy consortium. Int J Cardiol 218, 136-143 (2016).
18. Damman, K., et al. Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail 9, 872-878 (2007).
19. Tesch, G. H., et al. Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. J Clin Invest 103, 73-80 (1999).
20. Li, Z., et al. Increased serum interleukin-34 in patients with coronary artery disease. J Int Med Res 40, 1866-1870 (2012).
21. Zorena, K., Jachimowicz-Duda, O., Waz, P. The cut-off value for interleukin 34 as an additional potential inflammatory biomarker for the prediction of the risk of diabetic complications. Biomarkers 21, 276-282 (2016).
22. Wang, Y., Colonna, M. Interkeukin-34, a cytokine crucial for the differentiation and maintenance of tissue resident macrophages and Langerhans cells. Eur J Immunol 44, 1575-1581 (2014).
23. Eda, H., Shimada, H., Beidler, D. R., Monahan, J. B. Proinflammatory cytokines, IL-1beta and TNF-alpha, induce expression of interleukin-34 mRNA via JNK-and p44/42 MAPK-NF-kappaB pathway but not p38 pathway in osteoblasts. Rheumatol Int 31, 1525-1530 (2011).
24. Segaliny, A. I., et al. Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment. Int J Cancer 137, 73-85 (2015).
25. Preisser, L., et al. IL-34 and macrophage colony-stimulating factor are overexpressed in hepatitis C virus fibrosis and induce profibrotic macrophages that promote collagen synthesis by hepatic stellate cells. Hepatology 60, 1879-1890 (2014).
26. Wu, C. K., et al. Galectin-3 level and the severity of cardiac diastolic dysfunction using cellular and animal models and clinical indices. Sci Rep 5, 17007 (2015).
27. Bayes-Genis, A., et al. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3. J Am Coll Cardiol 63, 158-166 (2014).
28. Ho, J. E., et al. Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community. J Am Coll Cardiol 60, 1249-1256 (2012).
29. Gottlieb, S. S., et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail 8, 136-141 (2002).
30. Gensini, G. G. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51, 606 (1983).